TMDX LongTransMedics Group, Inc.BATS:TMDXProfit44lifeThink of this company like AMZN only in the organ transplant field Demand urgency is literally life or death and its a no brainer at these prices Their moat is not only but mainly regulatory in the USA since they are the only company that are licensed for heart, lung and kidney They are expanding to Europe so their margins might be under pressure for the next quarters Furthermore narrative was negative that due to higher oil prices margins are under more pressure, but since the decline in TMDX and crude this seems to be a clear divergence Original entry was at or below 70 but anything under 74 seems good now, no brainer long term For shorter term take profits are TP1: 86 TP2: at or above 100 That being said if next earnings disappoints a retrace to 70 or dip to 65 is not impossible